Skip to main content
. Author manuscript; available in PMC: 2019 Jun 24.
Published in final edited form as: N Engl J Med. 2018 Jan 24;378(8):708–718. doi: 10.1056/NEJMoa1713973

Figure 2. Scores on the Modified Rankin Scale at 90 Days.

Figure 2.

Patients in the endovascular-therapy group received endovascular therapy plus standard medical therapy. Patients in the medical-therapy group received standard medical therapy alone. Scores on the modified Rankin scale range from 0 to 6, with 0 indicating no symptoms, 1 no clinically significant disability, 2 slight disability, 3 moderate disability, 4 moderately severe disability, 5 severe disability, and 6 death. There was a significant difference favoring the endovascular-therapy group over the medical-therapy group in the overall distribution of scores (unadjusted common odds ratio, 2.77; 95% CI, 1.63 to 4.70; P<0.001).